| |
| |
| Exchange: |
Nasdaq National Market |
| Security
Type: |
Common |
| Shares
Out: |
138,140,000 |
| Market
Cap: |
142.28(M) |
| Last
Volume: |
3,241,097 |
Avg
Vol: |
3,286,692 |
| 52
Week Range: |
$0.92 - $1.31 |
|
| Level
I Sector: |
Health Care |
| Level
II Sector: |
Drugs |
| Level
III Sector: |
Drug Manufacturers - Major |
|
Member Indexes:
|
| |
NASDAQ COMPOSITE |
|
NASDAQ NNM COMPOSITE |
|
Rankings:
|
|
| Insider 3 Months : - |
| Insider 6 Months : - |
| Insider 3/6 Months : - |
|
| Guru Rank Number : 807 |
| Guru Rank Value : 1 |
| Guru Occurances : 1 |
|
|
|
|
|
| |
|
Company Profile Spectrum Pharmaceuticals is a biopharmaceutical company. Co. is engaged in acquiring, developing, and commercializing targeted oncology therapies. Co. has two drugs in late-stage development: Eflapegrastim, which is a long-acting granulocyte colony-stimulating factor for the treatment of chemotherapy-induced neutropenia; as well as Poziotinib, which is an irreversible tyrosine kinase inhibitor under investigation for non-small cell lung cancer tumors with various mutations.
|
|
|
D/I:
|
|
|
D
is for direct shares.
I is
for indirect shares.
D/I
refers to the Direct or Indirect
shares traded vs. held. |
|
|
|
Forms:
|
|
|
A
Form 4 is a form filed
by an insider to indicate a change
in ownership.
A Form
3 is a form filed by
an insider to indicate an
initial ownership of a security. |
|
|
|
3m +/-:
|
|
|
|
This
represents the company's 3 month
price change. The initial price
is based on the closing price
of the stock on the day the transaction
took place. Purchases & sales
are viewed as long & short
positions respectively.
|
|
|
|
Actions:
|
|
|
| B |
Buy |
| S |
Sell |
| OE |
Option
Exercised |
| A |
Acquired |
| D |
Disposed |
| AB |
Automatic
Buy |
| AS |
Automatic
Sell |
| IO |
Initial
Ownership |
|
|
|
|
Download:
|
|
|
Download only Transactions
Forms. (Default)
Download
only Summary Infomation.
Download
both Transactions and Summary Data
|
|
|
|
|
| |
| |
Summary (Direct Transactions Only)  |
3 Months |
6 Months |
12 Months |
24 Months |
| Total Shares Bought |
0 |
0 |
0 |
50,000 |
| Total Buy Value |
$0 |
$0 |
$0 |
$22,500 |
| Total People Bought |
0 |
0 |
0 |
1 |
| Total Buy Transactions |
0 |
0 |
0 |
1 |
| Total Shares Sold |
0 |
0 |
32,387 |
490,738 |
| Total Sell Value |
$0 |
$0 |
$35,496 |
$343,474 |
| Total People Sold |
0 |
0 |
1 |
7 |
| Total Sell Transactions |
0 |
0 |
1 |
19 |
| End Date |
2024-01-28 |
2023-10-27 |
2023-04-28 |
2022-04-28 |
|
| Filer's Name |
Relation Title |
Off-Dir-10% |
Tran. Date |
Form |
Action |
Price |
Mkt Value |
D/I |
Shares |
Holdings |
Rank
|
|
|
| 3m +/- |
|
|
Form |
  Mcgahan Keith M |
Chief Legal Officer |
• – – |
2020-04-01 |
4 |
AS |
$2.23 |
$3,271 |
D/D |
(1,467) |
285,968 |
|
49% |
|
| Gustafson Kurt A |
EVP & Chief Financial Officer |
• – – |
2020-04-01 |
4 |
AS |
$2.23 |
$6,991 |
D/D |
(3,135) |
360,830 |
|
49% |
|
| Turgeon Joseph W. |
CEO & President |
• • – |
2020-03-31 |
4 |
AS |
$2.31 |
$9,372 |
D/D |
(4,059) |
693,636 |
|
59% |
|
| Riga Thomas J |
EVP, COO & CCO |
• – – |
2020-03-31 |
4 |
AS |
$2.31 |
$4,281 |
D/D |
(1,854) |
420,582 |
|
59% |
|
| Mcgahan Keith M |
Chief Legal Officer |
• – – |
2020-03-31 |
4 |
AS |
$2.31 |
$4,124 |
D/D |
(1,786) |
287,435 |
|
59% |
|
| Gustafson Kurt A |
EVP & Chief Financial Officer |
• – – |
2020-03-31 |
4 |
AS |
$2.31 |
$9,989 |
D/D |
(4,326) |
363,965 |
|
59% |
|
| Lebel Francois |
Chief Medical Officer |
• – – |
2020-03-12 |
4 |
A |
$0.00 |
$0 |
D/D |
188,285 |
304,452 |
|
- |
|
| Mcgahan Keith M |
Chief Legal Officer |
• – – |
2020-03-12 |
4 |
A |
$0.00 |
$0 |
D/D |
163,180 |
289,221 |
|
- |
|
| Riga Thomas J |
EVP, COO & CCO |
• – – |
2020-03-12 |
4 |
A |
$0.00 |
$0 |
D/D |
188,285 |
422,436 |
|
- |
|
| Turgeon Joseph W. |
CEO & President |
• • – |
2020-03-12 |
4 |
A |
$0.00 |
$0 |
D/D |
282,427 |
697,695 |
|
- |
|
| Gustafson Kurt A |
EVP & Chief Financial Officer |
• – – |
2020-03-12 |
4 |
A |
$0.00 |
$0 |
D/D |
163,180 |
368,291 |
|
- |
|
| Gustafson Kurt A |
EVP & Chief Financial Officer |
• – – |
2020-02-20 |
4 |
AS |
$2.85 |
$9,499 |
D/D |
(3,333) |
205,111 |
|
10% |
|
| Mcgahan Keith M |
Chief Legal Officer |
• – – |
2020-02-20 |
4 |
AS |
$2.85 |
$7,601 |
D/D |
(2,667) |
126,041 |
|
10% |
|
| Riga Thomas J |
EVP, COO & CCO |
• – – |
2020-02-20 |
4 |
AS |
$2.85 |
$7,125 |
D/D |
(2,500) |
234,151 |
|
10% |
|
| Turgeon Joseph W. |
CEO & President |
• • – |
2020-02-20 |
4 |
AS |
$2.85 |
$10,688 |
D/D |
(3,750) |
415,268 |
|
10% |
|
| Gustafson Kurt A |
EVP & Chief Financial Officer |
• – – |
2020-02-19 |
4 |
AS |
$2.77 |
$13,115 |
D/D |
(4,733) |
208,444 |
|
7% |
|
| Mcgahan Keith M |
Chief Legal Officer |
• – – |
2020-02-19 |
4 |
AS |
$2.77 |
$9,258 |
D/D |
(3,341) |
128,708 |
|
7% |
|
| Riga Thomas J |
EVP, COO & CCO |
• – – |
2020-02-19 |
4 |
AS |
$2.77 |
$14,091 |
D/D |
(5,085) |
236,651 |
|
7% |
|
| Turgeon Joseph W. |
CEO & President |
• • – |
2020-02-19 |
4 |
AS |
$2.77 |
$17,352 |
D/D |
(6,262) |
419,018 |
|
7% |
|
| Mcgahan Keith M |
Chief Legal Officer |
• – – |
2020-02-10 |
4 |
AS |
$2.73 |
$4,551 |
D/D |
(1,667) |
132,049 |
|
18% |
|
| Mcgahan Keith M |
Chief Legal Officer |
• – – |
2020-02-07 |
4 |
AS |
$2.78 |
$5,620 |
D/D |
(2,020) |
133,716 |
|
13% |
|
| Turgeon Joseph W. |
CEO & President |
• • – |
2020-01-17 |
4 |
AS |
$3.33 |
$6,474 |
D/D |
(1,944) |
425,280 |
|
-8% |
|
| Gustafson Kurt A |
EVP & Chief Financial Officer |
• – – |
2020-01-17 |
4 |
AS |
$3.33 |
$5,398 |
D/D |
(1,621) |
231,955 |
|
-8% |
|
| Riga Thomas J |
EVP, COO & CCO |
• – – |
2020-01-17 |
4 |
AS |
$3.26 |
$16,301 |
D/D |
(5,000) |
241,678 |
|
-8% |
|
| Turgeon Joseph W. |
CEO & President |
• • – |
2020-01-16 |
4 |
AS |
$3.37 |
$12,636 |
D/D |
(3,753) |
427,224 |
|
-9% |
|
658 Records found
|
|
Page 7 of 27 |
|
|
